Multiple mechanisms are used for growth rate and stringent control of leuV transcriptional initiation in Escherichia coli

Expression of the Escherichia coli leuV operon, which contains three tRNA(1)(Leu) genes, is regulated by several mechanisms including growth-rate-dependent control (GRDC) and stringent control (SC). Structural variants of the leuV promoter which differentially affect these regulatory responses have...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of bacteriology 1999-09, Vol.181 (18), p.5771-5782
Hauptverfasser: Pokholok, D K, Redlak, M, Turnbough, Jr, C L, Dylla, S, Holmes, W M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 5782
container_issue 18
container_start_page 5771
container_title Journal of bacteriology
container_volume 181
creator Pokholok, D K
Redlak, M
Turnbough, Jr, C L
Dylla, S
Holmes, W M
description Expression of the Escherichia coli leuV operon, which contains three tRNA(1)(Leu) genes, is regulated by several mechanisms including growth-rate-dependent control (GRDC) and stringent control (SC). Structural variants of the leuV promoter which differentially affect these regulatory responses have been identified, suggesting that promoter targets for GRDC and SC may be different and that GRDC of the leuV promoter occurs in the absence of guanosine 3', 5'-bisdiphosphate. To determine the mechanisms of the leuV promoter regulation, we have examined the stability of promoter open complexes and the effects of nucleotide triphosphate (NTP) concentration on the efficiency of the leuV promoter and its structural variants in vitro and in vivo. The leuV promoter open complexes were an order of magnitude more stable to heparin challenge than those of rrnBp(1). The major initiating nucleotide GTP as well as other NTPs increased the stability of the leuV promoter open complexes. When the cellular level of purine triphosphates was increased at slower growth rates by pyrimidine limitation, a 10% reduction in leuV promoter activity was seen. It therefore appears that transcription initiation from the leuV promoter is less sensitive to changes in intracellular NTP concentration than that from rrnBp(1). Comparative analysis of regulation of the leuV promoter with and without upstream activating sequences (UAS) demonstrated that the binding site for factor of inversion stimulation (FIS) located in UAS is essential for maximal GRDC. Moreover, the presence of UAS overcame the effects of leuV promoter mutations, which abolished GRDC of the leuV core promoter. However, although the presence of putative FIS binding site was essential for optimal GRDC, both mutant and wild-type leuV promoters containing UAS showed improved GRDC in a fis mutant background, suggesting that FIS protein is an important but not unique participant in the regulation of the leuV promoter.
doi_str_mv 10.1128/JB.181.18.5771-5782.1999
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_94099</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>46529612</sourcerecordid><originalsourceid>FETCH-LOGICAL-c472t-a5012000c9b0fcd784fd2eeea750b3de47853bbecd43a02cd21a628c7bcf54903</originalsourceid><addsrcrecordid>eNpdkV1vFCEUhonR2LX6FwzxwrtZDwwskHhjm_rR1Hij3hKGYXZoWFiBqem_l8k2pnpxAoT3OTnwIIQJbAmh8t31xZZI0mrLhSAdF5JuiVLqCdoQULLjvIenaANASaeI6s_Qi1JuAQhjnD5HZwSYpJzCBt1_XUL1x-DwwdnZRF8OBZvs8FLciKeU8T6n33XG2VSHTRxxqdnHvYsV2xRrTgGnCQe3_MQ1m1hs9sfqUzQB--irN-uhbfFVsbPL3s7eNDL4l-jZZEJxrx7Wc_Tj49X3y8_dzbdPXy4_3HSWCVo7w4FQALBqgMmOQrJppM45IzgM_eiYkLwfBmdH1hugdqTE7Ki0YrATZwr6c_T-1Pe4DAc32jZ5NkEfsz-YfK-T8frfm-hnvU93WjFQquFvH_Ccfi2uVH3wxboQTHRpKZqIXuwkZy345r_gbVpy-4eiKRXAe7KTLSRPIZtTKdlNf-cgoFe1-vpCN7Wt9KpWr2r1qrahrx-_4xF4ctn_AUyDo_k</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>227053168</pqid></control><display><type>article</type><title>Multiple mechanisms are used for growth rate and stringent control of leuV transcriptional initiation in Escherichia coli</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Pokholok, D K ; Redlak, M ; Turnbough, Jr, C L ; Dylla, S ; Holmes, W M</creator><creatorcontrib>Pokholok, D K ; Redlak, M ; Turnbough, Jr, C L ; Dylla, S ; Holmes, W M</creatorcontrib><description>Expression of the Escherichia coli leuV operon, which contains three tRNA(1)(Leu) genes, is regulated by several mechanisms including growth-rate-dependent control (GRDC) and stringent control (SC). Structural variants of the leuV promoter which differentially affect these regulatory responses have been identified, suggesting that promoter targets for GRDC and SC may be different and that GRDC of the leuV promoter occurs in the absence of guanosine 3', 5'-bisdiphosphate. To determine the mechanisms of the leuV promoter regulation, we have examined the stability of promoter open complexes and the effects of nucleotide triphosphate (NTP) concentration on the efficiency of the leuV promoter and its structural variants in vitro and in vivo. The leuV promoter open complexes were an order of magnitude more stable to heparin challenge than those of rrnBp(1). The major initiating nucleotide GTP as well as other NTPs increased the stability of the leuV promoter open complexes. When the cellular level of purine triphosphates was increased at slower growth rates by pyrimidine limitation, a 10% reduction in leuV promoter activity was seen. It therefore appears that transcription initiation from the leuV promoter is less sensitive to changes in intracellular NTP concentration than that from rrnBp(1). Comparative analysis of regulation of the leuV promoter with and without upstream activating sequences (UAS) demonstrated that the binding site for factor of inversion stimulation (FIS) located in UAS is essential for maximal GRDC. Moreover, the presence of UAS overcame the effects of leuV promoter mutations, which abolished GRDC of the leuV core promoter. However, although the presence of putative FIS binding site was essential for optimal GRDC, both mutant and wild-type leuV promoters containing UAS showed improved GRDC in a fis mutant background, suggesting that FIS protein is an important but not unique participant in the regulation of the leuV promoter.</description><identifier>ISSN: 0021-9193</identifier><identifier>EISSN: 1098-5530</identifier><identifier>DOI: 10.1128/JB.181.18.5771-5782.1999</identifier><identifier>PMID: 10482520</identifier><identifier>CODEN: JOBAAY</identifier><language>eng</language><publisher>United States: American Society for Microbiology</publisher><subject>Bacteriology ; Base Sequence ; beta-Galactosidase - genetics ; beta-Galactosidase - metabolism ; Cloning, Molecular ; Escherichia coli ; Escherichia coli - cytology ; Escherichia coli - genetics ; Escherichia coli - growth &amp; development ; Gene Expression Regulation, Bacterial - drug effects ; Genetic Variation ; Genetics and Molecular Biology ; Guanosine Tetraphosphate - pharmacology ; Guanosine Triphosphate - metabolism ; Heparin - pharmacology ; leuV gene ; Microbiology ; Molecular Sequence Data ; Mutagenesis, Site-Directed ; Mutation ; Potassium Chloride - pharmacology ; Promoter Regions, Genetic ; Proteins ; Recombinant Proteins - metabolism ; Ribonucleic acid ; RNA ; RNA, Bacterial - genetics ; RNA, Transfer, Leu - genetics ; Sequence Deletion ; stringent response ; Transcription, Genetic - drug effects</subject><ispartof>Journal of bacteriology, 1999-09, Vol.181 (18), p.5771-5782</ispartof><rights>Copyright American Society for Microbiology Sep 1999</rights><rights>Copyright © 1999, American Society for Microbiology 1999</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c472t-a5012000c9b0fcd784fd2eeea750b3de47853bbecd43a02cd21a628c7bcf54903</citedby><cites>FETCH-LOGICAL-c472t-a5012000c9b0fcd784fd2eeea750b3de47853bbecd43a02cd21a628c7bcf54903</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC94099/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC94099/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10482520$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pokholok, D K</creatorcontrib><creatorcontrib>Redlak, M</creatorcontrib><creatorcontrib>Turnbough, Jr, C L</creatorcontrib><creatorcontrib>Dylla, S</creatorcontrib><creatorcontrib>Holmes, W M</creatorcontrib><title>Multiple mechanisms are used for growth rate and stringent control of leuV transcriptional initiation in Escherichia coli</title><title>Journal of bacteriology</title><addtitle>J Bacteriol</addtitle><description>Expression of the Escherichia coli leuV operon, which contains three tRNA(1)(Leu) genes, is regulated by several mechanisms including growth-rate-dependent control (GRDC) and stringent control (SC). Structural variants of the leuV promoter which differentially affect these regulatory responses have been identified, suggesting that promoter targets for GRDC and SC may be different and that GRDC of the leuV promoter occurs in the absence of guanosine 3', 5'-bisdiphosphate. To determine the mechanisms of the leuV promoter regulation, we have examined the stability of promoter open complexes and the effects of nucleotide triphosphate (NTP) concentration on the efficiency of the leuV promoter and its structural variants in vitro and in vivo. The leuV promoter open complexes were an order of magnitude more stable to heparin challenge than those of rrnBp(1). The major initiating nucleotide GTP as well as other NTPs increased the stability of the leuV promoter open complexes. When the cellular level of purine triphosphates was increased at slower growth rates by pyrimidine limitation, a 10% reduction in leuV promoter activity was seen. It therefore appears that transcription initiation from the leuV promoter is less sensitive to changes in intracellular NTP concentration than that from rrnBp(1). Comparative analysis of regulation of the leuV promoter with and without upstream activating sequences (UAS) demonstrated that the binding site for factor of inversion stimulation (FIS) located in UAS is essential for maximal GRDC. Moreover, the presence of UAS overcame the effects of leuV promoter mutations, which abolished GRDC of the leuV core promoter. However, although the presence of putative FIS binding site was essential for optimal GRDC, both mutant and wild-type leuV promoters containing UAS showed improved GRDC in a fis mutant background, suggesting that FIS protein is an important but not unique participant in the regulation of the leuV promoter.</description><subject>Bacteriology</subject><subject>Base Sequence</subject><subject>beta-Galactosidase - genetics</subject><subject>beta-Galactosidase - metabolism</subject><subject>Cloning, Molecular</subject><subject>Escherichia coli</subject><subject>Escherichia coli - cytology</subject><subject>Escherichia coli - genetics</subject><subject>Escherichia coli - growth &amp; development</subject><subject>Gene Expression Regulation, Bacterial - drug effects</subject><subject>Genetic Variation</subject><subject>Genetics and Molecular Biology</subject><subject>Guanosine Tetraphosphate - pharmacology</subject><subject>Guanosine Triphosphate - metabolism</subject><subject>Heparin - pharmacology</subject><subject>leuV gene</subject><subject>Microbiology</subject><subject>Molecular Sequence Data</subject><subject>Mutagenesis, Site-Directed</subject><subject>Mutation</subject><subject>Potassium Chloride - pharmacology</subject><subject>Promoter Regions, Genetic</subject><subject>Proteins</subject><subject>Recombinant Proteins - metabolism</subject><subject>Ribonucleic acid</subject><subject>RNA</subject><subject>RNA, Bacterial - genetics</subject><subject>RNA, Transfer, Leu - genetics</subject><subject>Sequence Deletion</subject><subject>stringent response</subject><subject>Transcription, Genetic - drug effects</subject><issn>0021-9193</issn><issn>1098-5530</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkV1vFCEUhonR2LX6FwzxwrtZDwwskHhjm_rR1Hij3hKGYXZoWFiBqem_l8k2pnpxAoT3OTnwIIQJbAmh8t31xZZI0mrLhSAdF5JuiVLqCdoQULLjvIenaANASaeI6s_Qi1JuAQhjnD5HZwSYpJzCBt1_XUL1x-DwwdnZRF8OBZvs8FLciKeU8T6n33XG2VSHTRxxqdnHvYsV2xRrTgGnCQe3_MQ1m1hs9sfqUzQB--irN-uhbfFVsbPL3s7eNDL4l-jZZEJxrx7Wc_Tj49X3y8_dzbdPXy4_3HSWCVo7w4FQALBqgMmOQrJppM45IzgM_eiYkLwfBmdH1hugdqTE7Ki0YrATZwr6c_T-1Pe4DAc32jZ5NkEfsz-YfK-T8frfm-hnvU93WjFQquFvH_Ccfi2uVH3wxboQTHRpKZqIXuwkZy345r_gbVpy-4eiKRXAe7KTLSRPIZtTKdlNf-cgoFe1-vpCN7Wt9KpWr2r1qrahrx-_4xF4ctn_AUyDo_k</recordid><startdate>19990901</startdate><enddate>19990901</enddate><creator>Pokholok, D K</creator><creator>Redlak, M</creator><creator>Turnbough, Jr, C L</creator><creator>Dylla, S</creator><creator>Holmes, W M</creator><general>American Society for Microbiology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7TM</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>5PM</scope></search><sort><creationdate>19990901</creationdate><title>Multiple mechanisms are used for growth rate and stringent control of leuV transcriptional initiation in Escherichia coli</title><author>Pokholok, D K ; Redlak, M ; Turnbough, Jr, C L ; Dylla, S ; Holmes, W M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c472t-a5012000c9b0fcd784fd2eeea750b3de47853bbecd43a02cd21a628c7bcf54903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Bacteriology</topic><topic>Base Sequence</topic><topic>beta-Galactosidase - genetics</topic><topic>beta-Galactosidase - metabolism</topic><topic>Cloning, Molecular</topic><topic>Escherichia coli</topic><topic>Escherichia coli - cytology</topic><topic>Escherichia coli - genetics</topic><topic>Escherichia coli - growth &amp; development</topic><topic>Gene Expression Regulation, Bacterial - drug effects</topic><topic>Genetic Variation</topic><topic>Genetics and Molecular Biology</topic><topic>Guanosine Tetraphosphate - pharmacology</topic><topic>Guanosine Triphosphate - metabolism</topic><topic>Heparin - pharmacology</topic><topic>leuV gene</topic><topic>Microbiology</topic><topic>Molecular Sequence Data</topic><topic>Mutagenesis, Site-Directed</topic><topic>Mutation</topic><topic>Potassium Chloride - pharmacology</topic><topic>Promoter Regions, Genetic</topic><topic>Proteins</topic><topic>Recombinant Proteins - metabolism</topic><topic>Ribonucleic acid</topic><topic>RNA</topic><topic>RNA, Bacterial - genetics</topic><topic>RNA, Transfer, Leu - genetics</topic><topic>Sequence Deletion</topic><topic>stringent response</topic><topic>Transcription, Genetic - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pokholok, D K</creatorcontrib><creatorcontrib>Redlak, M</creatorcontrib><creatorcontrib>Turnbough, Jr, C L</creatorcontrib><creatorcontrib>Dylla, S</creatorcontrib><creatorcontrib>Holmes, W M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of bacteriology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pokholok, D K</au><au>Redlak, M</au><au>Turnbough, Jr, C L</au><au>Dylla, S</au><au>Holmes, W M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multiple mechanisms are used for growth rate and stringent control of leuV transcriptional initiation in Escherichia coli</atitle><jtitle>Journal of bacteriology</jtitle><addtitle>J Bacteriol</addtitle><date>1999-09-01</date><risdate>1999</risdate><volume>181</volume><issue>18</issue><spage>5771</spage><epage>5782</epage><pages>5771-5782</pages><issn>0021-9193</issn><eissn>1098-5530</eissn><coden>JOBAAY</coden><abstract>Expression of the Escherichia coli leuV operon, which contains three tRNA(1)(Leu) genes, is regulated by several mechanisms including growth-rate-dependent control (GRDC) and stringent control (SC). Structural variants of the leuV promoter which differentially affect these regulatory responses have been identified, suggesting that promoter targets for GRDC and SC may be different and that GRDC of the leuV promoter occurs in the absence of guanosine 3', 5'-bisdiphosphate. To determine the mechanisms of the leuV promoter regulation, we have examined the stability of promoter open complexes and the effects of nucleotide triphosphate (NTP) concentration on the efficiency of the leuV promoter and its structural variants in vitro and in vivo. The leuV promoter open complexes were an order of magnitude more stable to heparin challenge than those of rrnBp(1). The major initiating nucleotide GTP as well as other NTPs increased the stability of the leuV promoter open complexes. When the cellular level of purine triphosphates was increased at slower growth rates by pyrimidine limitation, a 10% reduction in leuV promoter activity was seen. It therefore appears that transcription initiation from the leuV promoter is less sensitive to changes in intracellular NTP concentration than that from rrnBp(1). Comparative analysis of regulation of the leuV promoter with and without upstream activating sequences (UAS) demonstrated that the binding site for factor of inversion stimulation (FIS) located in UAS is essential for maximal GRDC. Moreover, the presence of UAS overcame the effects of leuV promoter mutations, which abolished GRDC of the leuV core promoter. However, although the presence of putative FIS binding site was essential for optimal GRDC, both mutant and wild-type leuV promoters containing UAS showed improved GRDC in a fis mutant background, suggesting that FIS protein is an important but not unique participant in the regulation of the leuV promoter.</abstract><cop>United States</cop><pub>American Society for Microbiology</pub><pmid>10482520</pmid><doi>10.1128/JB.181.18.5771-5782.1999</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9193
ispartof Journal of bacteriology, 1999-09, Vol.181 (18), p.5771-5782
issn 0021-9193
1098-5530
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_94099
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Bacteriology
Base Sequence
beta-Galactosidase - genetics
beta-Galactosidase - metabolism
Cloning, Molecular
Escherichia coli
Escherichia coli - cytology
Escherichia coli - genetics
Escherichia coli - growth & development
Gene Expression Regulation, Bacterial - drug effects
Genetic Variation
Genetics and Molecular Biology
Guanosine Tetraphosphate - pharmacology
Guanosine Triphosphate - metabolism
Heparin - pharmacology
leuV gene
Microbiology
Molecular Sequence Data
Mutagenesis, Site-Directed
Mutation
Potassium Chloride - pharmacology
Promoter Regions, Genetic
Proteins
Recombinant Proteins - metabolism
Ribonucleic acid
RNA
RNA, Bacterial - genetics
RNA, Transfer, Leu - genetics
Sequence Deletion
stringent response
Transcription, Genetic - drug effects
title Multiple mechanisms are used for growth rate and stringent control of leuV transcriptional initiation in Escherichia coli
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T02%3A53%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multiple%20mechanisms%20are%20used%20for%20growth%20rate%20and%20stringent%20control%20of%20leuV%20transcriptional%20initiation%20in%20Escherichia%20coli&rft.jtitle=Journal%20of%20bacteriology&rft.au=Pokholok,%20D%20K&rft.date=1999-09-01&rft.volume=181&rft.issue=18&rft.spage=5771&rft.epage=5782&rft.pages=5771-5782&rft.issn=0021-9193&rft.eissn=1098-5530&rft.coden=JOBAAY&rft_id=info:doi/10.1128/JB.181.18.5771-5782.1999&rft_dat=%3Cproquest_pubme%3E46529612%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=227053168&rft_id=info:pmid/10482520&rfr_iscdi=true